相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Serum Hepatitis B Virus-DNA Levels Correlate With Long-term Adverse Outcomes in Spontaneous Hepatitis B e Antigen Seroconverters
Tai-Chung Tseng et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Hepatitis B e Antigen Seroconversion: A Critical Event in Chronic Hepatitis B Virus Infection
Yun-Fan Liaw et al.
DIGESTIVE DISEASES AND SCIENCES (2010)
Nucleos(t)ide Analogues Only Induce Temporary Hepatitis B e Antigen Seroconversion in Most Patients With Chronic Hepatitis B
Jurrien G. P. Reijnders et al.
GASTROENTEROLOGY (2010)
Age-Specific Prognosis Following Spontaneous Hepatitis B e Antigen Seroconversion in Chronic Hepatitis B
Yi-Cheng Chen et al.
HEPATOLOGY (2010)
Lamivudine Maintenance Beyond One Year After HBeAg Seroconversion Is a Major Factor for Sustained Virologic Response in HBeAg-Positive Chronic Hepatitis B
Hyun Woong Lee et al.
HEPATOLOGY (2010)
Long-Term Entecavir Therapy Results in the Reversal of Fibrosis/Cirrhosis and Continued Histological Improvement in Patients with Chronic Hepatitis B
Ting-Tsung Chang et al.
HEPATOLOGY (2010)
Hepatitis B virus genotyping by enzyme-linked immunosorbent assay in Taiwan
Shu-Fen Liu et al.
HEPATOLOGY INTERNATIONAL (2010)
The Duration of Lamivudine Therapy for Chronic Hepatitis B: Cessation vs. Continuation of Treatment After HBeAg Seroconversion
James Fung et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Long-term Outcome of Hepatitis B e Antigen-Negative Hepatitis B Surface Antigen Carriers in Relation to Changes of Alanine Aminotransferase Levels Over Time
Dar-In Tai et al.
HEPATOLOGY (2009)
Withdrawal of lamivudine in HBeAg-positive chronic hepatitis B patients after achieving effective maintained virological suppression
Chau-Ting Yeh et al.
JOURNAL OF CLINICAL VIROLOGY (2009)
EASL Clinical Practice Guidelines: Management of chronic hepatitis B
Patrick Marcellin et al.
JOURNAL OF HEPATOLOGY (2009)
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update
Yun-Fan Liaw et al.
HEPATOLOGY INTERNATIONAL (2008)
A higher alanine aminotransferase level correlates with earlier hepatitis B e antigen seroconversion in lamivudine-treated chronic hepatitis B patients
Tai-Chung Tseng et al.
LIVER INTERNATIONAL (2008)
Viral factors correlate with hepatitis B e antigen seroconverson in patients with chronic hepatitis B
Chun-Jen Liu et al.
LIVER INTERNATIONAL (2006)
Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels
CM Chu et al.
AMERICAN JOURNAL OF MEDICINE (2004)
Lamivudine for patients with chronic hepatitis B and advanced liver disease
YF Liaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Quantification and genotyping of hepatitis B virus in a single reaction by real-time PCR and melting curve analysis
SH Yeh et al.
JOURNAL OF HEPATOLOGY (2004)
Hepatitis B virus genotypes and hepatocellular carcinoma in Taiwan
JH Kao
INTERVIROLOGY (2003)
Hepatitis B e antigen and the risk of hepatocellular carcinoma
HI Yang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Predictors of HBeAg loss after lamivudine treatment for chronic hepatitis B
RP Perrillo et al.
HEPATOLOGY (2002)
Global control of hepatitis B virus infection
JH Kao et al.
LANCET INFECTIOUS DISEASES (2002)
Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B
YS Hsu et al.
HEPATOLOGY (2002)
分享论文
